Body and Mind Past Earnings Performance

Past criteria checks 0/6

Body and Mind's earnings have been declining at an average annual rate of -44.2%, while the Pharmaceuticals industry saw earnings growing at 45.6% annually. Revenues have been growing at an average rate of 25.1% per year.

Key information

-44.2%

Earnings growth rate

-35.5%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate25.1%
Return on equityn/a
Net Margin-98.3%
Last Earnings Update30 Apr 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Body and Mind makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CNSX:BAMM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Apr 2423-2380
31 Jan 2423-1680
31 Oct 2322-1790
31 Jul 2323-2180
30 Apr 2313-2970
31 Jan 2317-2970
31 Oct 2220-3070
31 Jul 2223-2970
30 Apr 2232-670
31 Jan 2231-470
31 Oct 2129-270
31 Jul 2127-270
30 Apr 2120-370
31 Jan 2114-460
31 Oct 209-460
31 Jul 205-460
30 Apr 205-550
31 Jan 205-440
31 Oct 195-440
31 Jul 195-440
30 Apr 194-230
31 Jan 194-230
31 Oct 184-220
31 Jul 182-220
30 Apr 181-220
31 Jan 181-220
31 Oct 170-110
31 Jul 170000
30 Apr 170000
31 Jan 170000
31 Oct 160000
31 Jul 160000
30 Apr 160000
31 Jan 160000
31 Oct 150000
31 Jul 150000
30 Apr 150000
31 Jan 150000
31 Oct 140000
31 Jul 140000
30 Apr 140000

Quality Earnings: BAMM is currently unprofitable.

Growing Profit Margin: BAMM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BAMM is unprofitable, and losses have increased over the past 5 years at a rate of 44.2% per year.

Accelerating Growth: Unable to compare BAMM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BAMM is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-51.1%).


Return on Equity

High ROE: BAMM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 00:56
End of Day Share Price 2024/12/24 00:00
Earnings2024/04/30
Annual Earnings2023/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Body and Mind Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution